SCM
MIRM icon

Semanteon Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Semanteon Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,653
Closed -$561K – 110
2025
Q3 		$561K Buy
+7,653
New +$487K 0.7% 82
2025
Q2 		– Sell
-31,478
Closed -$1.42M – 202
2025
Q1 		$1.42M Buy
+31,478
New +$1.48M 0.77% 43
2024
Q3 		– Sell
-11,252
Closed -$385K – 266
2024
Q2 		$385K Buy
+11,252
New +$295K 0.27% 136

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Semanteon Capital Management's MIRM Position: Q4 2025 in Review

Semanteon Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 7,653 shares — an estimated $561K sold.

Semanteon Capital Management first reported a position in MIRM in Q2 2024 and held it in 3 quarters. The position peaked at $1.42M in Q1 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Semanteon Capital Management reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Semanteon Capital Management sold 7,653 Mirum Pharmaceuticals shares in Q4 2025, an estimated $561K.
  • Semanteon Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Semanteon Capital Management's Mirum Pharmaceuticals position peaked at $1.42M in Q1 2025.
  • 281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Semanteon Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.